The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glycobiology Market Research Report 2024
Synopsis
The global Glycobiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glycobiology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glycobiology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Glycobiology in Drug Discovery and Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Glycobiology include Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme and New England Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycobiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycobiology.
Report Scope
The Glycobiology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycobiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycobiology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Bruker Corp
Waters Corp
Thermo Fisher Scientific
Takara Bio
Merck
Shimadzu Corp
Prozyme
New England Biolabs
Danaher Corp
Segment by Type
Reagents
Instruments
Kits
Enzymes
Segment by Application
Drug Discovery and Development
Immunology
Diagnostics
Oncology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycobiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Glycobiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glycobiology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glycobiology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Glycobiology in Drug Discovery and Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Glycobiology include Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme and New England Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycobiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycobiology.
Report Scope
The Glycobiology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycobiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycobiology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Bruker Corp
Waters Corp
Thermo Fisher Scientific
Takara Bio
Merck
Shimadzu Corp
Prozyme
New England Biolabs
Danaher Corp
Segment by Type
Reagents
Instruments
Kits
Enzymes
Segment by Application
Drug Discovery and Development
Immunology
Diagnostics
Oncology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycobiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycobiology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagents
1.2.3 Instruments
1.2.4 Kits
1.2.5 Enzymes
1.3 Market by Application
1.3.1 Global Glycobiology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery and Development
1.3.3 Immunology
1.3.4 Diagnostics
1.3.5 Oncology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glycobiology Market Perspective (2019-2030)
2.2 Glycobiology Growth Trends by Region
2.2.1 Global Glycobiology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glycobiology Historic Market Size by Region (2019-2024)
2.2.3 Glycobiology Forecasted Market Size by Region (2025-2030)
2.3 Glycobiology Market Dynamics
2.3.1 Glycobiology Industry Trends
2.3.2 Glycobiology Market Drivers
2.3.3 Glycobiology Market Challenges
2.3.4 Glycobiology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glycobiology Players by Revenue
3.1.1 Global Top Glycobiology Players by Revenue (2019-2024)
3.1.2 Global Glycobiology Revenue Market Share by Players (2019-2024)
3.2 Global Glycobiology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glycobiology Revenue
3.4 Global Glycobiology Market Concentration Ratio
3.4.1 Global Glycobiology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycobiology Revenue in 2023
3.5 Glycobiology Key Players Head office and Area Served
3.6 Key Players Glycobiology Product Solution and Service
3.7 Date of Enter into Glycobiology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glycobiology Breakdown Data by Type
4.1 Global Glycobiology Historic Market Size by Type (2019-2024)
4.2 Global Glycobiology Forecasted Market Size by Type (2025-2030)
5 Glycobiology Breakdown Data by Application
5.1 Global Glycobiology Historic Market Size by Application (2019-2024)
5.2 Global Glycobiology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Glycobiology Market Size (2019-2030)
6.2 North America Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Glycobiology Market Size by Country (2019-2024)
6.4 North America Glycobiology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glycobiology Market Size (2019-2030)
7.2 Europe Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Glycobiology Market Size by Country (2019-2024)
7.4 Europe Glycobiology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glycobiology Market Size (2019-2030)
8.2 Asia-Pacific Glycobiology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Glycobiology Market Size by Region (2019-2024)
8.4 Asia-Pacific Glycobiology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glycobiology Market Size (2019-2030)
9.2 Latin America Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Glycobiology Market Size by Country (2019-2024)
9.4 Latin America Glycobiology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glycobiology Market Size (2019-2030)
10.2 Middle East & Africa Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Glycobiology Market Size by Country (2019-2024)
10.4 Middle East & Africa Glycobiology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Glycobiology Introduction
11.1.4 Agilent Technologies Revenue in Glycobiology Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Bruker Corp
11.2.1 Bruker Corp Company Detail
11.2.2 Bruker Corp Business Overview
11.2.3 Bruker Corp Glycobiology Introduction
11.2.4 Bruker Corp Revenue in Glycobiology Business (2019-2024)
11.2.5 Bruker Corp Recent Development
11.3 Waters Corp
11.3.1 Waters Corp Company Detail
11.3.2 Waters Corp Business Overview
11.3.3 Waters Corp Glycobiology Introduction
11.3.4 Waters Corp Revenue in Glycobiology Business (2019-2024)
11.3.5 Waters Corp Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Glycobiology Introduction
11.4.4 Thermo Fisher Scientific Revenue in Glycobiology Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Glycobiology Introduction
11.5.4 Takara Bio Revenue in Glycobiology Business (2019-2024)
11.5.5 Takara Bio Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Glycobiology Introduction
11.6.4 Merck Revenue in Glycobiology Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Shimadzu Corp
11.7.1 Shimadzu Corp Company Detail
11.7.2 Shimadzu Corp Business Overview
11.7.3 Shimadzu Corp Glycobiology Introduction
11.7.4 Shimadzu Corp Revenue in Glycobiology Business (2019-2024)
11.7.5 Shimadzu Corp Recent Development
11.8 Prozyme
11.8.1 Prozyme Company Detail
11.8.2 Prozyme Business Overview
11.8.3 Prozyme Glycobiology Introduction
11.8.4 Prozyme Revenue in Glycobiology Business (2019-2024)
11.8.5 Prozyme Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Glycobiology Introduction
11.9.4 New England Biolabs Revenue in Glycobiology Business (2019-2024)
11.9.5 New England Biolabs Recent Development
11.10 Danaher Corp
11.10.1 Danaher Corp Company Detail
11.10.2 Danaher Corp Business Overview
11.10.3 Danaher Corp Glycobiology Introduction
11.10.4 Danaher Corp Revenue in Glycobiology Business (2019-2024)
11.10.5 Danaher Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
